Mark W. Womack is BioCina’s Chief Executive Officer, and in his first 9 months at the helm he led BioCina to a 500% YOY increase in sales and a 250% YOY increase in revenue. Following BioCina’s merger with NovaCina in January 2025 (with the combined company retaining the BioCina name), Mr. Womack created a powerful brand in biopharmaceutical and small molecule contract manufacturing, with an end-to-end offering, including clinical and commercial drug substance and sterile fill-finish of drug products. Prior to BioCina, as CEO of KBI Biopharma and Selexis SA, Mr. Womack led the company to a run rate of over a 30% YOY revenue increase in only 6 months and implemented a new commercial strategy to generate significantly greater deal size and profitability. Before that, as CEO and Managing Director of Stelis Biopharma, he led Stelis to build and qualify a state-of-the-art vaccine facility in record time, while also generating over $200M in new sales, and leading the development and implementation of Stelis’ operations infrastructure as a newly formed end-to-end Biologics CDMO.
Preceding Stelis, as the CBO for AGC Biologics, one of the world’s leading global biopharma CDMO’s, Mr. Womack led the organization to nearly a 300% increase in new sales in just two years. Over these two years, he drove the acquisition of many of the top Large Pharma companies into the AGC Biologics Client portfolio. Due to his extensive experience driving operational performance improvements, Mr. Womack led numerous major initiatives that achieved step changes in key indicators of AGC’s client program delivery success. Prior to the AGC Biologics board appointing him to the role of CBO, he led the development of their brand strategy for the newly formed company and then led the global integration of the three former CDMO’s that were merged to create AGC Biologics.
Prior to joining AGC Biologics, Mr. Womack served over 20 years as a management consulting industry leader and C-level client advisor, guiding many of the world’s renowned companies to achieve record highs in revenue and profit—while leaving behind a Fortune 500 list of stronger leaders. He joined the management consulting industry with Capgemini as a Principal and within three years became a leader of large-scale transformations of elite client companies, including a $20B post-merger integration within General Motors. In 2001, Mr. Womack became EVP, Head of Consulting Operations—Americas, for Celerant Consulting. He led the organization to deliver client benefits of as much as over $100 million per engagement and all-time highs in top and bottom-line growth for Celerant. In 2003, he founded his own boutique executive management consultancy, J.W. Webb Inc. For 11 years, J.W. Webb served elite clients such as Bayer HealthCare, CMC Biologics, Coors Brewing Company, and Whirlpool. Following that, Mr. Womack served as the COO for two international management consulting companies, delivering new sales generating as much as a 250% annual revenue increase.
Mr. Womack began his professional journey by leading a succession of U.S. Navy units to unprecedented results, including while serving as a combat center leader on a destroyer class ship. As Director of Training and Development for one of the world’s premier military technical training facilities, his command prepared many service personnel for key roles in the Desert Storm conflict. During his military career, he was honored with numerous of the Navy’s highest honors and awards. Mr. Womack has been quoted as a key source in The New York Times, Fast Company and many other major global media outlets and has been the keynote speaker on the topic of Achieving Disciplined Execution at numerous major corporate events around the world.